Stay updated on Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added and Revision v3.4.2 was removed from the Study Record Versions.
    Difference
    0.1%
    Check dated 2026-03-11T16:35:51.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    - Revision: v3.4.2 added to the record history; the funding/operating status notice shown in v3.4.1 was removed.
    Difference
    0.9%
    Check dated 2026-02-11T06:16:34.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a new page revision tag (v3.4.1) and a site-wide notice about government funding and NIH Clinical Center operations; the previous revision tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T05:44:22.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The new screenshot shows UI updates on the Record History page, including a Show glossary option and color-coded highlights for additions and deletions. Versioning and wording changes, such as Revision: v3.4.0 and references to No FEAR Act Data, are presentation details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T04:18:04.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The Record History shows addition of Revision: v3.3.4 and removal of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:15:27.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the record history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T10:17:59.000Z thumbnail image

Stay in the know with updates to Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.